health
Podcast Advertising for Pharma and Biotech Brands
Pharma and biotech marketing is notoriously hard. Audiences are skeptical, regulations are strict, and the buyer journey often spans months or years. Podcast advertising for pharma brands has emerged as one of the sharpest tools available for cutting through that clutter, reaching both healthcare professionals and patients in a format built on trust.
The numbers confirm the shift. Pharma companies spent more on podcast ads in the first two months of 2023 than in the previous five years combined, according to a CMI Media Group and Compas survey reported by Fierce Pharma. This is not an experiment. It is a category reallocation.
Why Podcast Advertising for Pharma Brands Is Growing
The audience math is straightforward. Edison Research’s Infinite Dial 2025 reports that 55% of Americans aged 12 and older now listen to podcasts monthly. That is a highly educated, high-income group: the same demographic that indexes heavily for healthcare decision-making, both as patients and professionals.
But reach alone is not the argument. The format is.
Podcast listeners are engaged in a way that most digital ad recipients are not. They choose to spend 30 to 60 minutes with a host they trust, and that trust transfers to the ads embedded in the show. Sounds Profitable’s Advertising Landscape 2025 research found that 86% of regular podcast listeners recalled hearing an ad in the past week. No other ad-supported medium comes close.
That recall matters enormously for pharma, where a single message often needs to land with a listener before they talk to their doctor, or with a physician before they consider a new treatment protocol.
Podcast advertising revenue reached $2.862 billion in 2025, up 17.6% year-over-year, according to the IAB/PwC Internet Advertising Revenue Report. Pharma has a growing seat at that table.
Reaching Healthcare Professionals Through Podcasts
The HCP channel is where pharma’s podcast opportunity is most distinct. Physicians, nurses, pharmacists, and other clinicians are consuming more audio content than ever. Podcasts fit the way they learn: during commutes, during procedures, during the gaps that a journal article or webinar cannot fill.
Source: CMI Media Group and Compas, 2023 Annual Medical Brand Survey, via Fierce Pharma
That one-in-five figure understates the actual behavior. The same survey found many more HCPs listen regularly without rating podcasts as a primary resource. The audience is there. The intent to engage is high.
Wolters Kluwer’s research on HCP podcast advertising adds a critical nuance: HCPs remember podcast ads more than ads in other channels, including social media, and say those ads influence the changes they make in their practices. That is a direct line from impression to prescribing behavior.
Show categories that reach HCPs
- Therapeutic area podcasts: Shows focused on oncology, cardiology, endocrinology, and other specialties attract the exact prescribers a brand needs.
- CME-accredited programs: Continuing medical education podcasts have a built-in professional audience completing required learning hours.
- Medical society productions: Professional associations run shows for their members. Sponsoring these places your brand in a trusted, contextually appropriate setting.
- General medical news: Broadly consumed across specialties, these shows offer scale for launches where cross-specialty awareness matters.
Direct-to-Patient Campaigns: Reaching the Informed Patient
DTC podcast advertising targets patients who are researching conditions, treatment options, or managing ongoing health decisions. General health and wellness podcasts, condition-specific patient community shows, and caregiver-focused programs all deliver these audiences.
The trust transfer from host to brand is powerful here. A National Public Media and Veritonic case study from 2026 found that 42% of NPR podcast listeners reported a favorable opinion of a healthcare brand that advertised on the network. Non-listeners came in 14 points lower.
That is a meaningful brand lift in a channel where pharma has historically struggled to build affinity outside of mass-market TV.
What makes a pharma host-read spot work
The same ingredients that work for any host-read ad apply in pharma, with one addition: clarity. Keep the spot grounded in real patient experience. Work with the host so the message lands as an honest endorsement rooted in lived context. Avoid clinical jargon that belongs in prescribing information, not in a conversational ad.
Compliance: Running Pharma Podcast Ads Responsibly
Podcast advertising does not exist outside FDA oversight. DTC advertising for prescription drugs must include fair balance information about risks and side effects. In practice, this means either a longer mid-roll spot that includes the required safety information, or an unbranded disease awareness campaign that drives listeners to a URL where they can learn more.
Many pharma brands start with unbranded campaigns for exactly this reason. A disease awareness campaign on a relevant podcast builds audience and category understanding without triggering fair balance requirements. When the brand has established trust, a branded campaign layer follows.
OTC medications and supplements face far lighter restrictions and can run standard host-read spots with less complexity. For biotech and clinical-stage companies, unbranded pipeline awareness and condition education campaigns are often the right entry point.
Practical compliance checkpoints
- Run creative through MLR review before any spot goes live.
- Build approval timelines into the campaign plan. Podcast campaigns require lead time.
- Choose a managed service partner with documented pharma advertising experience and category controls.
- Use promo codes and vanity URLs that are easy to say aloud and track through the approval process.
The majority of pharma marketers have already made the call to invest. The question is how to execute well.
Show Selection and Campaign Planning
Podcast advertising effectiveness in pharma is largely determined by show selection. The wrong show delivers the wrong audience, regardless of how good the creative is.
For HCP campaigns, start with shows in your specific therapeutic area. Narrow is better. A cardiovascular drug brand advertising on a general business podcast is wasting budget on listeners who will never prescribe or influence prescribing. A cardiology-focused show with 10,000 engaged cardiologist listeners delivers orders of magnitude more value per CPM.
For DTC campaigns, match the show audience to your patient profile. Use the Wildcast Audience Finder to identify shows whose listeners match the demographics and condition interests of your target patients.
Budget-wise, health and wellness shows typically run host-read CPMs in the $25 to $40 range. Niche HCP-targeted shows command higher rates because the audience is worth more per impression to a pharma advertiser.
How podcast advertising for pharma brands works
Pharma and biotech advertisers reach healthcare professionals and patients through podcast advertising by selecting shows in relevant therapeutic areas, running host-read or produced spots compliant with FDA guidance, and measuring results through promo codes, vanity URLs, and brand lift studies. Unbranded disease awareness campaigns are a proven starting point for prescription drug brands.
Ready to Reach Patients and Prescribers?
Podcast advertising gives pharma and biotech brands what few other channels can: a direct line to engaged, trusting audiences already seeking health information and making care decisions.
Explore the Wildcast Audience Finder to find shows reaching your specific patient population or HCP audience, or get started with Wildcast.
Sources
- CMI Media Group and Compas, 2023 Annual Medical Brand Survey, via Fierce Pharma. https://www.fiercepharma.com/marketing/hcps-embrace-podcasts-stay-abreast-drug-options-survey
- Edison Research, Infinite Dial 2025. https://www.edisonresearch.com/the-infinite-dial-2025/
- IAB/PwC Internet Advertising Revenue Report 2025, via RBRI. https://rbr.com/iab-digital-audio-grew-10-in-2025/
- Sounds Profitable, The Advertising Landscape 2025. https://soundsprofitable.com/research/the-advertising-landscape-2025-part-two-attention-and-trust/
- National Public Media and Veritonic, 2026. https://www.nationalpublicmedia.com/insights/articles/npr-podcasts-connect-online-pharmaceutical-company-with-health-minded-parents/
- MM&M 2024 survey, via Pharma Marketing Network. https://www.pharma-mkting.com/articles/pharma-podcast-marketing/
- Wolters Kluwer, Essential Facts HCP Marketers Must Know About Podcast Advertising, 2024. https://www.wolterskluwer.com/en/expert-insights/essential-facts-hcp-marketers-must-know-about-podcast-advertising